1. Home
  2. BIAF vs OMH Comparison

BIAF vs OMH Comparison

Compare BIAF & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • OMH
  • Stock Information
  • Founded
  • BIAF 2014
  • OMH 2015
  • Country
  • BIAF United States
  • OMH Singapore
  • Employees
  • BIAF N/A
  • OMH N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OMH Real Estate
  • Sector
  • BIAF Health Care
  • OMH Finance
  • Exchange
  • BIAF Nasdaq
  • OMH Nasdaq
  • Market Cap
  • BIAF 12.2M
  • OMH 13.6M
  • IPO Year
  • BIAF 2022
  • OMH 2023
  • Fundamental
  • Price
  • BIAF $0.29
  • OMH $1.45
  • Analyst Decision
  • BIAF Hold
  • OMH Hold
  • Analyst Count
  • BIAF 1
  • OMH 1
  • Target Price
  • BIAF N/A
  • OMH N/A
  • AVG Volume (30 Days)
  • BIAF 11.2M
  • OMH 5.5M
  • Earning Date
  • BIAF 08-13-2025
  • OMH 07-11-2025
  • Dividend Yield
  • BIAF N/A
  • OMH N/A
  • EPS Growth
  • BIAF N/A
  • OMH N/A
  • EPS
  • BIAF N/A
  • OMH N/A
  • Revenue
  • BIAF $8,809,228.00
  • OMH $7,976,578.00
  • Revenue This Year
  • BIAF N/A
  • OMH $28.40
  • Revenue Next Year
  • BIAF $20.00
  • OMH $23.07
  • P/E Ratio
  • BIAF N/A
  • OMH N/A
  • Revenue Growth
  • BIAF 78.40
  • OMH 117.53
  • 52 Week Low
  • BIAF $0.16
  • OMH $0.59
  • 52 Week High
  • BIAF $2.99
  • OMH $6.20
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 50.96
  • OMH 46.11
  • Support Level
  • BIAF $0.22
  • OMH $1.45
  • Resistance Level
  • BIAF $0.46
  • OMH $1.59
  • Average True Range (ATR)
  • BIAF 0.04
  • OMH 0.40
  • MACD
  • BIAF 0.01
  • OMH 0.02
  • Stochastic Oscillator
  • BIAF 30.51
  • OMH 35.76

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: